Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Anacor Pharmaceutica (NASDAQ: ANAC)

$99.06 USD -$0.14 (-0.14%)
Last Price $99.06
Net Change $-0.14 (-0.14%)
Bid $
Ask Price $
Open Price $99.06
Previous Close Price $99.2
High Price $99.06
Low Price $99.06
Number of Trades 0
Volume 300
Fifty Two Week High $156.93 (2015-07-21)
Fifty Two Week Low $52 (2016-04-01)
Average Daily Volume 1,809,178
Share Outstanding 44,860 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $-0.36 (2016-05-10)
2nd Quarter Earnings $-0.43 (2016-02-29)
3nd Quarter Earnings $-0.37 (2015-11-03)
4th Quarter Earnings $-0.3 (2015-08-06)
PE Ratio $0
EPS Growth $-21.58
Recent Earnings $-0.36
Annual EPS $-1.46
Last Quarter EPS $
Market Capitalization $4.44B
Insider Shareholders % 0.045%
Annual Revenue $0B
No. Shares Outstanding 44,860
Inst. Shareholder % 0%
Annual Net Income $-0.06B
TTM Net Profit Margin $-76.14
1-Year Return 28.25%
3-Year Return 121.15%
5-Year Return 1365.29%
5-Year Revenue Growth 196.05%
5-Year Earnings Growth -48.71%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD -21.58%
Dividends per Share $
Stock Split Ratio
Beta 1.53
Anacor Pharmaceuticals, Inc. is a biopharmaceutical company engaged in discovery, development and commercialization of novel small-molecule therapeutics derived from its boron chemistry platform. Its three lead product candidates include two topically administered dermatologic compounds-AN2690, an antifungal for the treatment of onychomycosis, and AN2728, an anti-inflammatory for the treatment of psoriasis, as well as a systemic antibiotic for the treatment of infections caused by Gram-negative bacteria-GSK2251052. Additionally, the Company also develops topical antifungal product for the treatment of onychomycosis and skin fungal infections, topical anti-inflammatory product for the treatment of psoriasis and atopic dermatitis. Anacor Pharmaceuticals, Inc. is headquartered in Palo Alto, California.

ANAC News & Stock Updates